Tag: Zubslov

August 2, 2017 Off

Orexo’s Zubsolv tablet on the CVS Caremark formulary

By Dino Mustafić

Orexo AB said on Wednesday that Zubsolv tablet’s position has changed from excluded from reimbursement to reimbursed as a preferred product. Zubsolv is buprenorphine and naloxone sublingual tablet (CIII) managed care formulary position with CVS Caremark for patients suffering from opioid dependence.